The present disclosure is related to patient support apparatuses that provide air fluidized therapy. More specifically, the present disclosure is related to patient support apparatuses that provide air fluidized therapy and additional therapies utilizing the functionality of the air fluidized therapy system of the patient support apparatus.
Patient support apparatuses that provide air fluidized therapy are well known in the art and are considered to be a specialized use device that supports at least a portion of the patient on the air fluidized section when the patient has highly compromised skin. For example burn patients, severe diabetics, or compromised elderly patients may be supported on the air fluidized therapy which has been shown to help reduce further injury and promote healing of the compromised skin. In general, patient support apparatuses that provide air fluidized therapy do not provide other therapies may be found in beds or mattresses that do not provide air fluidized therapy.
The present application discloses one or more of the features recited in the appended claims and/or the following features which, alone or in any combination, may comprise patentable subject matter:
According to a first aspect of the present disclosure, a patient support apparatus comprises an air supply, an air fluidization therapy bed, and a pulsator coupled to the air fluidization therapy bed. The air fluidization therapy bed includes a fluidization space and a fluidizable medium positioned in the fluidization space. The air fluidization therapy bed receives a flow of pressurized air from the air supply. The flow of pressurized air is operable to fluidize the fluidizable medium. The pulsator is positioned to transmit air pulses through the fluidized fluidizable medium to impart a percussive force to a body supported on air fluidization therapy bed.
In some embodiments, the pulsator is in fluid communication with the air supply and operable to form air pulses from at least a portion of the flow from the air supply.
In some embodiments, the frequency and magnitude of the air pulses are variable.
In some embodiments, the patient support apparatus further comprises a percussion/vibration controller operable to control the operation of the pulsator.
In some embodiments, the patient support apparatus further comprises a controller and a user interface, the user interface isoperable to receive inputs from a user indicative of at least one desired operating parameter of the percussion/vibration controller, the controller operable to modify the operation of the percussion/vibration controller to achieve the desired operating parameter.
In some embodiments, the patient support apparatus comprises a first conduit, a tap coupled to the first conduit, a second conduit coupled to the tap and the pulsator, a third conduit coupled to the tap and the air fluidization therapy bed, the third conduit smaller than the first conduit and the second conduit.
In some embodiments, the pulsator comprises a valve that is openable to allow air to flow through the second conduit and the valve of the pulsator. In some embodiments, the valve of the pulsator is in communication with the space of the air fluidization therapy bed such that when the valve opens, air flows through the valve into the space. In some embodiments, the valve opens and closes to create air pulses in the space of the air fluidization therapy bed.
In some embodiments, the air supply has a variable output, the output being modified to compensate for the flow of air used to provide the percussive forces.
According to another aspect of the present disclosure, a patient support apparatus comprises an air supply, a first patient support zone comprising an air fluidization therapy bed, a second patient support zone comprising a plurality of inflatable support bladders, and a sonic emitter. The first patient support zone includes a fluidization space and a fluidizable medium positioned in the fluidization space. The air fluidization therapy bed receives a flow of pressurized air from the air supply. The flow of pressurized air is operable to fluidize the fluidizable medium. The sonic emitter is coupled to the second portion and positioned to transmit sonic waves through the bladders to impart a percussive force to a body supported on the second portion.
In some embodiments, the sonic emitter has a variable frequency and amplitude.
In some embodiments, the patient support apparatus further comprises a sonic controller operable to control the frequency and amplitude of the sonic emitter.
In some embodiments, the patient support apparatus further includes a controller operable to control the fluid supply and the sonic controller.
In some embodiments, the patient support apparatus further includes a user interface, the user interface operable to accept a user input indicative of a desired operating parameter of the sonic emitter.
In some embodiments, the controller modifies operation of the sonic controller to achieve the desired operating parameter of the sonic emitter.
In some embodiments, the second patient support zone is movable relative to the first patient support zone.
In some embodiments, the sonic emitter is coupled to the second patient support zone to move therewith.
According to yet another aspect of the present disclosure, a patient support apparatus comprises an air supply, a first patient support zone comprising an air fluidization therapy bed, a second patient support zone comprising a plurality of inflatable support bladders, and a percussion assembly. The first patient support zone comprises a fluidization space and a fluidizable medium positioned in the fluidization space. The air fluidization therapy bed receives a flow of pressurized air from the air supply. The flow of pressurized air is operable to fluidize the fluidizable medium. The percussion assembly is coupled to the second portion. The percussion assembly includes a plurality of chambers. Each chamber includes a vent and is positioned to impart a percussive force to a body supported on the second portion when the chamber is inflated.
In some embodiments, the patient support apparatus further comprises a plurality of conduits, each conduit coupled to a respective chamber. In some embodiments, the patient support apparatus comprises a plurality of valves, each valve associated with one of the conduits coupled to a respective chamber. In some embodiments, the patient support apparatus includes a percussion/vibration controller that is operable to control the operation of the valves to selectively inflate the chambers. In some embodiments, the valves are coupled to the air supply such that opening of one of the plurality of valves permits a flow of air from the air supply to a respective chamber. In some embodiments, the vents of the chambers are sized such that they constrict flow out of each chamber, and wherein the flow of the air from the air supply is sufficient to rapidly expand the chamber when a valve is opened, the vent allowing the expanded chamber to contract when the valve is closed.
In some embodiments, the patient support apparatus further comprises a percussion/vibration controller operable to control the frequency and amplitude of the inflations of the chambers.
In some embodiments, the patient support apparatus further includes a controller operable to control the fluid supply and the percussion/vibration controller.
In some embodiments, the patient support apparatus further includes a user interface, the user interface operable to accept a user input indicative of a desired operating parameter of the percussion/vibration controller.
In some embodiments, the controller modifies operation of the percussion/vibration controller to achieve the desired operating parameter of the percussion/vibration controller.
In some embodiments, the second patient support zone is movable relative to the first patient support zone.
In some embodiments, the percussion assembly is coupled to the second patient support zone to move therewith.
According to still another aspect of the present disclosure, a patient support apparatus comprises an air supply, a first patient support zone comprising an air fluidization therapy bed, and a garment coupled to the air supply. The air fluidization therapy bed includes a fluidization space and a fluidizable medium positioned in the fluidization space. The air fluidization therapy bed receives a flow of pressurized air from the air supply. The flow of pressurized air is operable to fluidize the fluidizable medium. The garment includes a plurality of chambers. Each chamber includes a vent. Each chamber is positioned to impart a percussive force to a the body of a patient wearing the garment when a chamber is inflated.
In some embodiments, the patient support apparatus further comprises a plurality of conduits, each conduit coupled to a respective chamber.
In some embodiments, the patient support apparatus comprises a plurality of valves, each valve associated with one of the conduits coupled to a respective chamber.
In some embodiments, the patient support apparatus includes a percussion/vibration controller that is operable to control the operation of the valves to selectively inflate the chambers.
In some embodiments, the valves are coupled to the air supply such that opening of one of the plurality of valves permits a flow of air from the air supply to a respective chamber.
In some embodiments, the vents of the chambers are sized such that they constrict flow out of each chamber, and wherein the flow of the air from the air supply is sufficient to rapidly expand the chamber when a valve is opened, the vent allowing the expanded chamber to contract when the valve is closed.
In some embodiments, the patient support apparatus further comprises a percussion/vibration controller operable to control the frequency and amplitude of the inflations of the chambers.
In some embodiments, the patient support apparatus further includes a controller operable to control the fluid supply and the percussion/vibration controller.
In some embodiments, the patient support apparatus further includes a user interface, the user interface operable to accept a user input indicative of a desired operating parameter of the percussion/vibration controller.
In some embodiments, the controller modifies operation of the percussion/vibration controller to achieve the desired operating parameter of the percussion/vibration controller.
In some embodiments, the patient support apparatus further comprises a second patient support zone comprising a plurality of inflatable support bladders.
In some embodiments, the second patient support zone is movable relative to the first patient support zone.
According to still another aspect of the present disclosure, a patient support apparatus comprises an air supply, a first patient support zone comprising an air fluidization therapy bed, a second patient support zone comprising a plurality of inflatable support bladders, and a micro-climate assembly coupled to the second portion. The air fluidization therapy bed includes a fluidization space and a fluidizable medium positioned in the fluidization space. The air fluidization therapy bed receives a flow of pressurized air from the air supply. The flow of pressurized air is operable to fluidize the fluidizable medium. The micro-climate assembly includes an upper layer of vapor permeable material and a lower layer coupled to the upper layer to define a chamber having an inlet and an outlet. The chamber defines an interior space. A three dimensional material is positioned in the interior space. The micro-climate assembly is coupled to the air supply to selectively receive a flow of pressurized air from the air supply. The flow of air enters the chamber through the inlet and exiting the chamber through the outlet.
In some embodiments, the patient support apparatus includes a first conduit from the air supply to the air fluidization therapy bed.
In some embodiments, the patient support apparatus further comprises a valve coupled to the first conduit and a second conduit coupled to the valve, the second conduit coupled to the micro-climate assembly.
In some embodiments, the patient support apparatus further comprises a controller operable to control the valve to selectively direct a flow of air from the air supply to the micro-climate assembly.
In some embodiments, the patient support apparatus further includes a sonic emitter operable to impart a percussive force to a patient supported on the patient support apparatus.
In some embodiments, the patient support apparatus further includes a garment coupled to the air supply, the garment including a plurality of chambers, each chamber including a vent and positioned to impart a percussive force to a the body of a patient wearing the garment when the chamber is inflated.
In some embodiments, the patient support apparatus further includes a percussion assembly coupled to the second portion, the percussion assembly including a plurality of chambers, each chamber including a vent and positioned to impart a percussive force to a body supported on the second portion when the chamber is inflated.
Additional features, which alone or in combination with any other feature(s), including those listed above and those listed in the claims, may comprise patentable subject matter and will become apparent to those skilled in the art upon consideration of the following detailed description of illustrative embodiments exemplifying the best mode of carrying out the invention as presently perceived.
The detailed description particularly refers to the accompanying figures in which:
A patient support apparatus 10, illustratively embodied as an air fluidized therapy bed, includes a surface 12 on which a patient who has highly compromised skin may be positioned to receive therapy is shown in
The patient support apparatus 10 includes a head end 34 and a foot end 32. The lower frame 16 is supported on a plurality of casters 20 which facilitate movement of the patient support apparatus 10 over a floor. The lower frame 16 supports an upper frame 18 upon which the tank 14 is mounted. In other embodiments, the perimeter structure may be an inflatable bladder. An air supply 30 is supported on the lower frame 16 and provides a high volume of pressurized air to the tank 14 to fluidize the fluidizable medium 28 as will be discussed in further detail below.
Referring now to
Because patients who require AFT tend to be quite ill and in a highly compromised state, they often require other therapeutic treatments beyond the AFT available on the AFT bed 10. In the illustrative embodiment of
The tank 14 includes a tank base 42, a tank liner 40, a tank bladder 44, and the filter sheet 24 as shown in
The filter sheet 24 is positioned over the opening 26 and is coupled to the tank liner 40 as shown in
The diffuser 50 is configured to support the fluidizable medium 28 thereon and provide substantially uniform fluid flow to the fluidizable medium 28 from the air supply 30 as suggested, for example, in
The pulsator 52 receives air from the air supply 30 through a tap 62 from a conduit 64 between the air supply 30 and the inlet 58. The pulsator 52 includes a quick acting valve that opens and closes very quickly. The flow path through a conduit 66 from the tap 62 to the inlet 49 has a first diameter that tends to limit flow from the air supply 30 into the space 48. A conduit 68 from the tap 62 to the pulsator 52 allows for a higher flow of air to pass therethrough and to the pulsator 52. The pulsator 52, under the control of a controller 70 as shown in the block diagram in
The AFT bed 10 includes the controller 70 that operates both the pulsator 52 and the air supply 30. The air supply 30 includes a variable speed blower 72 that is operable to vary the volume of air flowing through the conduit 64, under the control of a processor 74 which is in communication with a memory device 75, the memory device 75 including instructions that, when executed by the processor 74 causes the processor 74 to control operation of the patient support apparatus 10. In addition, the AFT bed 10 includes a user interface 76 that includes a display 78 and a plurality of user inputs 80 that are operable to change the operation of the AFT bed 10. For example, a user may choose to activate the pulsator 52 and may choose a frequency, magnitude, and duration of the percussion/vibration therapy. In addition, a user may vary the speed of the blower 72 to adjust the fluidization of the fluidizable medium 28. In the illustrative embodiment, the user interface 76 includes a touchscreen 79 that also includes the user inputs 80 on the display. In other embodiments, the display 78 may be a simple multi-segment LED display and the user inputs 80 may be discrete buttons or switches.
In another embodiment shown in
The present disclosure includes embodiments that deliver additional therapies, generally pulmonary therapies, to patients who are candidates for air fluidized therapy. In the embodiment shown in
Referring to
The controller 126 also controls a sonic controller 128 which is operable to drive the sonic emitter 134 to generate sonic waves through the bladders 130 which then impinge upon the upper body of a patient supported on the second portion 114. The sonic controller 128 includes a frequency generator 152 and an amplifier 154. A user is able to select a particular percussive or vibration therapy from the user interface 139 which controls the magnitude and frequency of the sonic pulses from the sonic emitter 134.
Referring now to
Being coupled to the head deck section 160, the sonic emitter 134 moves with the head deck section 160 as it pivots about the axis 162. Thus, percussion and/or vibration therapy may be delivered to the patient 36 as the head deck section 160 moves between a lowered position as shown in
In yet another embodiment, shown in
Referring to the block diagram of
In operation, each conduit 232, 234, 236, 238, 240 is associated with a respective valve that is openable to allow air to flow into the respective chambers 222, 224, 226, 228, and 230. Each chamber 222, 224, 226, 228, and 230 is vented to atmosphere such that a burst of air into a chamber 222, 224, 226, 228, and 230 will expand the chamber 222, 224, 226, 228, or 230. The vents of the chambers 222, 224, 226, 228, and 230 are sized to constrict flow through the 222, 224, 226, 228, or 230 so that the chamber 222, 224, 226, 228, or 230 is rapidly expanded, thereby imparting a force onto the upper body of the patient 36. After the rapid expansion, closing of the respective valve causes the respective chambers to deflate back to the deflated state shown in
In still yet another embodiment shown in
The garment 320 causes high frequency chest wall oscillation of the patient, which is known to help with relieving pulmonary congestion, such as that experienced by those who suffer from cystic fibrosis. In some embodiments, the garment 320 and the percussion/vibration controller 244 function similarly to the apparatus disclosed in U.S. Patent Application Publication No. 2011/0087143, entitled “THREE-DIMENSIONAL LAYER FOR A GARMENT OF A HFCWO SYSTEM” which is incorporated by reference herein in its entirety.
In yet another embodiment, shown in
The micro-climate management assembly 416 includes an upper layer 418 that comprises a urethane coated nylon ticking material that is air impermeable but vapor permeable. The upper layer 418 permits moisture, such as sweat, to permeate into an interior space 420 which includes a second layer 426 that comprises a three-dimensional spacer material that is sufficiently porous to permit air to flow therethrough. As air is introduced, under pressure, to an inlet 422 of the micro-climate management assembly 416, the air is urged through the second layer 426 in the direction of an arrow 424. The air flows through the second layer and moves moisture that has collected in the interior space 420 through the second layer 426 an urges the air and moisture out of an outlet 428. This action tends to cool the patient's skin and remove excess moisture, thereby reducing the potential for skin injury. A third layer 429 is coupled to the upper layer 418 to enclose the interior space 420.
The inlet 422 also comprises urethane coated nylon ticking material that is air impermeable but vapor permeable and is positioned between the bladders 130 and the first portion 112 of the patient support apparatus 410. The inlet 422 is a pliable material and is not prone to pinching or reduced flow due to mechanical interferences.
The flow to the micro-climate management assembly 416 is controlled by a controller 430 as shown in
Further disclosure of a micro-climate assembly may be found in U.S. Application No. PCT/US09/40661, filed Apr. 15, 2009 and entitled MICROCLIMATE MANAGEMENT SYSTEM which is incorporated in its entirety by reference herein.
Although certain illustrative embodiments have been described in detail above, variations and modifications exist within the scope and spirit of this disclosure as described and as defined in the following claims.
This present application claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application Ser. No. 61/778,789, entitled “AIR FLUIDIZED THERAPY BED HAVING PULMONARY THERAPY,” which was filed on Mar. 13, 2013, the entirety of which is hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
1772310 | Hart | Aug 1930 | A |
3008465 | Andrew | Nov 1961 | A |
3428973 | Hargest et al. | Feb 1969 | A |
3492988 | Mare | Feb 1970 | A |
3674019 | Grant | Jul 1972 | A |
3866606 | Hargest et al. | Feb 1975 | A |
3867732 | Morrell | Feb 1975 | A |
3955563 | Maione et al. | May 1976 | A |
4193149 | Welch | Mar 1980 | A |
4224706 | Young et al. | Sep 1980 | A |
4347633 | Gammons et al. | Sep 1982 | A |
4371997 | Mattson | Feb 1983 | A |
4394784 | Swenson et al. | Jul 1983 | A |
4435864 | Callaway et al. | Mar 1984 | A |
4481686 | Lacoste | Nov 1984 | A |
4483029 | Paul | Nov 1984 | A |
4508107 | Strom et al. | Apr 1985 | A |
4517693 | Viesturs | May 1985 | A |
4525409 | Elesh | Jun 1985 | A |
4564965 | Goodwin | Jan 1986 | A |
4599755 | Tominaga | Jul 1986 | A |
4609854 | Yamamoto et al. | Sep 1986 | A |
4628557 | Murphy | Dec 1986 | A |
4637083 | Goodwin | Jan 1987 | A |
4638519 | Hess | Jan 1987 | A |
4684486 | Ricchio et al. | Aug 1987 | A |
4686722 | Swart et al. | Aug 1987 | A |
4689844 | Alivizatos | Sep 1987 | A |
4694520 | Paul et al. | Sep 1987 | A |
4694521 | Tominaga | Sep 1987 | A |
4723328 | Kato et al. | Feb 1988 | A |
4753225 | Vogel | Jun 1988 | A |
4768250 | Kato | Sep 1988 | A |
4794659 | Kurita et al. | Jan 1989 | A |
4803744 | Peck et al. | Feb 1989 | A |
4837880 | Coffman et al. | Jun 1989 | A |
4879777 | Goodwin | Nov 1989 | A |
4897890 | Walker et al. | Feb 1990 | A |
4914760 | Hargest et al. | Apr 1990 | A |
4942635 | Hargest et al. | Jul 1990 | A |
4951335 | Eady | Aug 1990 | A |
4967431 | Hargest et al. | Nov 1990 | A |
4977633 | Chaffee | Dec 1990 | A |
4982466 | Higgins et al. | Jan 1991 | A |
4986738 | Kawasaki et al. | Jan 1991 | A |
4991244 | Walker et al. | Feb 1991 | A |
4993920 | Harkleroad et al. | Feb 1991 | A |
4999867 | Toivio et al. | Mar 1991 | A |
5007123 | Salyards | Apr 1991 | A |
5008965 | Vrzalik | Apr 1991 | A |
5018786 | Goldstein et al. | May 1991 | A |
5029352 | Hargest et al. | Jul 1991 | A |
5036559 | Hargest | Aug 1991 | A |
5044364 | Crowther | Sep 1991 | A |
5052068 | Graebe | Oct 1991 | A |
5060174 | Gross | Oct 1991 | A |
5062169 | Kennedy et al. | Nov 1991 | A |
5068933 | Sexton et al. | Dec 1991 | A |
5074286 | Gillaspie et al. | Dec 1991 | A |
5083335 | Krouskop et al. | Jan 1992 | A |
5095568 | Thomas et al. | Mar 1992 | A |
5103519 | Hasty et al. | Apr 1992 | A |
5109560 | Uetake | May 1992 | A |
5109561 | Schild | May 1992 | A |
5142719 | Vrzalik et al. | Sep 1992 | A |
5152021 | Vrzalik et al. | Oct 1992 | A |
5170364 | Gross et al. | Dec 1992 | A |
5179742 | Oberle | Jan 1993 | A |
5325551 | Tappel et al. | Jul 1994 | A |
5331698 | Newkirk et al. | Jul 1994 | A |
5335384 | Foster et al. | Aug 1994 | A |
5367728 | Chang et al. | Nov 1994 | A |
5375273 | Bodine et al. | Dec 1994 | A |
5454126 | Foster et al. | Oct 1995 | A |
5487196 | Wilkinson et al. | Jan 1996 | A |
5539943 | Romano | Jul 1996 | A |
5586346 | Stacy | Dec 1996 | A |
5606754 | Hand et al. | Mar 1997 | A |
5611096 | Bartlett et al. | Mar 1997 | A |
5623736 | Soltani et al. | Apr 1997 | A |
5666681 | Meyer et al. | Sep 1997 | A |
6016581 | Miki | Jan 2000 | A |
6073289 | Bolden et al. | Jun 2000 | A |
6119291 | Osborne et al. | Sep 2000 | A |
6158070 | Bolden et al. | Dec 2000 | A |
6192537 | Miki | Feb 2001 | B1 |
6202672 | Ellis | Mar 2001 | B1 |
6302145 | Ellis et al. | Oct 2001 | B1 |
6327932 | Onodera et al. | Dec 2001 | B1 |
6351862 | Henley et al. | Mar 2002 | B1 |
6353948 | Bolden et al. | Mar 2002 | B1 |
6415814 | Hand et al. | Jul 2002 | B1 |
6439264 | Ellis et al. | Aug 2002 | B1 |
6564412 | Henley et al. | May 2003 | B2 |
6574813 | Bolden et al. | Jun 2003 | B2 |
6694555 | Soltani et al. | Feb 2004 | B2 |
6721979 | Vrzalik et al. | Apr 2004 | B1 |
6735801 | Henley et al. | May 2004 | B2 |
6820640 | Hand et al. | Nov 2004 | B2 |
6953439 | Kabemba | Oct 2005 | B1 |
7107642 | Wong et al. | Sep 2006 | B2 |
7219380 | Beck et al. | May 2007 | B2 |
7451506 | Kummer et al. | Nov 2008 | B2 |
7458119 | Hornbach et al. | Dec 2008 | B2 |
7509698 | Poulos | Mar 2009 | B2 |
7536739 | Poulos | May 2009 | B2 |
7587776 | Poulos | Sep 2009 | B2 |
7641623 | Biondo et al. | Jan 2010 | B2 |
7657956 | Stacy et al. | Feb 2010 | B2 |
7698765 | Bobey et al. | Apr 2010 | B2 |
7716766 | Poulos | May 2010 | B2 |
7802332 | Kummer et al. | Sep 2010 | B2 |
7975335 | O'Keefe et al. | Jul 2011 | B2 |
8038632 | Flick et al. | Oct 2011 | B2 |
8056165 | Kummer et al. | Nov 2011 | B2 |
8108957 | Richards et al. | Feb 2012 | B2 |
8146191 | Bobey et al. | Apr 2012 | B2 |
8151391 | Frias | Apr 2012 | B2 |
8196240 | Meyer et al. | Jun 2012 | B2 |
8286282 | Kummer et al. | Oct 2012 | B2 |
8397326 | Lafleche et al. | Mar 2013 | B2 |
8397327 | O'Reagan | Mar 2013 | B2 |
8413271 | Blanchard et al. | Apr 2013 | B2 |
8474074 | O'Keefe et al. | Jul 2013 | B2 |
8572778 | Newkirk et al. | Nov 2013 | B2 |
8584279 | Richards et al. | Nov 2013 | B2 |
8590731 | Pinelli | Nov 2013 | B2 |
8603017 | Trandafir et al. | Dec 2013 | B2 |
8707483 | Richards et al. | Apr 2014 | B2 |
8727176 | Ei-Saden et al. | May 2014 | B2 |
8734370 | Ignagni | May 2014 | B1 |
8789222 | Blanchard et al. | Jul 2014 | B2 |
8795210 | Talish et al. | Aug 2014 | B2 |
8803682 | Wong et al. | Aug 2014 | B2 |
8832885 | Lafleche et al. | Sep 2014 | B2 |
20010052152 | Soltani | Dec 2001 | A1 |
20060053558 | Ye | Mar 2006 | A1 |
20060168736 | Meyer et al. | Aug 2006 | A1 |
20080235872 | Newkirk et al. | Oct 2008 | A1 |
20080263776 | O'Reagan et al. | Oct 2008 | A1 |
20110138538 | Howell | Jun 2011 | A1 |
20110296623 | Lafleche et al. | Dec 2011 | A1 |
20110296624 | Lafleche et al. | Dec 2011 | A1 |
20120096644 | Heimbrock | Apr 2012 | A1 |
20120172959 | Lachenbruch et al. | Jul 2012 | A1 |
20130074271 | Klink et al. | Mar 2013 | A1 |
Number | Date | Country |
---|---|---|
2006269277 | Jan 2007 | AU |
2006269277 | Feb 2012 | AU |
317009 | Jan 1992 | EP |
332242 | Aug 1992 | EP |
1723877 | Nov 2006 | EP |
1139966 | May 2008 | EP |
2233118 | Sep 2010 | EP |
1901635 | May 2013 | EP |
2586413 | May 2013 | EP |
2682085 | Jan 2014 | EP |
2546403 | Nov 1984 | FR |
2897774 | Aug 2007 | FR |
2457702 | Aug 2009 | GB |
S6122860 | Jan 1986 | JP |
9841180 | Sep 1998 | WO |
2007008723 | Jan 2007 | WO |
2007047379 | Apr 2007 | WO |
2011097569 | Aug 2011 | WO |
Entry |
---|
Search Report, EP14159207.1, 9 pgs. |
Search report for related European Application No. 15158895.1-1658, dated Jul. 20, 2015, 6 pages. |
Extended Search report for related European Application No. 15158895.1-1658, dated Nov. 5, 2015, 6 pages. |
European Office Action for EP Application No. 16172750.8, dated Jun. 22, 2018, 6 pages. |
Number | Date | Country | |
---|---|---|---|
20140259428 A1 | Sep 2014 | US |
Number | Date | Country | |
---|---|---|---|
61778789 | Mar 2013 | US |